http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014102209-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
filingDate 2012-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2014102209-A
titleOfInvention WATER COMPOSITION CONTAINING BIOLOGICAL ANTIGEN AND ACRYLIC ACID POLYMER
abstract 1. An aqueous composition containing a biological antigen and a polymer of acrylic acid, the composition containing an electrolyte to provide a higher osmolarity than the osmolarity of an aqueous solution of 0.9% w / v sodium chloride. 2. A composition according to claim 1, wherein the osmolarity of the composition is at least 50% higher than the osmolarity of the solution of 0.9% w / v sodium chloride. The composition according to claim 1, containing more than 0.2 wt. % polymer of acrylic acid. 4. A composition according to claim 3, containing more than 0.5 wt. % polymer of acrylic acid. 5. The composition according to claim 4, containing from 0.8 to 1.6 wt. % polymer of acrylic acid. 6. The composition of claim 1, wherein the acrylic acid polymer is a crosslinked polymer. A composition according to claim 6, wherein the acrylic acid polymer is crosslinked using a polyalkenyl ether, polyhydric alcohol and / or divinyl glycol. A composition according to claim 1, comprising an electrolyte comprising a multiply charged cation. The composition of claim 8, wherein the cation is present in a concentration of up to 0.05 M, preferably up to 0.03 M. The composition of claim 1, wherein the biological antigen is an antigen that, when administered, causes an elevated temperature. The composition of claim 10, wherein the antigen is selected from the group consisting of a gram-negative bacterial antigen and a circovirus antigen. The composition of claim 10, wherein the antigen is selected from the group consisting of Actinobacillus pleuropneumoniae antigen, Haemophilus parasuis antigen, and porcine circovirus antigen of the second type. The composition according to claim 1, containing the pig antigen of the second type and the bacterial antigen Mycoplasma hyopneumoniae for use as a vaccine, which, after a single dose
priorityDate 2011-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414874708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14042
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID46221
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID46221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID715
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581

Total number of triples: 32.